Now in JNC! ASNC’s President and JNC‘s Editor-in-Chief Weigh In
In their final editorials of the year, ASNC President Panithaya Chareonthaitawee, MD, MASNC, and Journal of Nuclear Cardiology Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, share observations about the field of nuclear cardiology – frontiers that are expanding and trends that are emerging.
Writing independently, Drs. Chareonthaitawee and Di Carli arrived at the same word to describe nuclear cardiology’s evolution in 2025 and their expectations for 2026. Both physicians landed on the idea of convergence. Forces from within and outside of nuclear cardiology are coming together, they say, and the result will be a new chapter for the field, one with many exciting opportunities to advance patient care.
“A theme that has run through this year … is convergence. Imaging is no longer defined by single modalities or single metrics. Instead, we see technology, biology, and clinical insight coming together in new and meaningful ways.”
– Marcelo F. Di Carli, MD, MASNC,
in his JNC Editor’s Page
“Our field is entering a new area where precision imaging, data science, and patient-centered care are converging. The next chapter will demand creativity, adaptability, and collaboration. ASNC is ready.”
– Panithaya Chareonthaitawee, MD, MASNC,
in her ASNC President’s Message
It’s Your Turn! Share Your Word of the Year
As you look back on 2025 and forward to 2026, what word or theme describes your nuclear cardiology experience? Share it with us on X (formerly Twitter). Be sure to tag @MyASNC and include #CVNuc. We look forward to your thoughts and to seeing you in the new year.
Article Type
JNC News
Category
Journal of Nuclear Cardiology (JNC)
Related Posts
New Podcast! Is PET the Key to Finally Getting Heart Disease Diagnoses Right for Women?
Episode 13 of JNC CardioConnect highlights the results of the landmark AURORA…
Key to Clarity Lies in Direct Measurement of Flow, Says JNC Editor-in-Chief
“As coronary artery disease becomes more diffuse and functionally mediated, the diagnostic…
More HMDP Coming in Late March, Radiopharmaceutical Manufacturer Says
Following supply issues starting in January, ASNC is maintaining close contact with…


